Clinical Trial Update: Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing lobectomy and segmentectomy for early-stage peripheral non-small cell lung cancer (cT1aN0M0); current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN